Prof. Giorgio Walter Canonica is the Head of Personalized Medicine Center: Asthma and Allergy in Humanitas Research Hospital.
Medical areas of interest:
Asthma and allergies
Research areas of interest:
T cells: study of different subgroups and their functional role in basic and clinical research (allergy, specific autoimmunity of organs, degenerative diseases of the CNS and cancer).
Molecular events and interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airway remodelling.
Biomarkers that define the therapeutic response in asthma.
New antiallergenic drugs and new strategies in the treatment of allergic disease.
Clinical and immune-pharmacological activities of modifiers of biological responses such as cytokines, monoclonal antibodies, specific immunotherapy for allergens, etc.
Results of reported patients and assessment of quality of life in patients with respiratory and allergic diseases.
Prof. Canonica coordinated and conducted more than 50 tests (phase II-IV) according to current GCP rules (certification number 2426574, 29/06/2017).
He has also served as an arbitrator for most of the most important international journals - Editor-in-Chief of "Current Opinion in Allergy and Clinical Immunology" – Associated Editor "Annals of Allergy & Clinical Immunology".
Previous experience:
Director of the Degree programme of Lung Diseases at the University of Genoa (1998 - Today) President of the Clinic for Diseases of Allergies and Respiratory - Department of Internal Medicine, University of Genoa - IRCCS AOU San Martino IST
(1997) Director of the Specialized School of Allergy and Clinical Immunology DIMI, University of Genoa
Publications:
https://www.ncbi.nlm.nih.gov/pubmed/?term=giorgio+walter+canonica
اقرأ المزيدProf. Giorgio Walter Canonica is the Head of Personalized Medicine Center: Asthma and Allergy in Humanitas Research Hospital.
Medical areas of interest:
Asthma and allergies
Research areas of interest:
T cells: study of different subgroups and their functional role in basic and clinical research (allergy, specific autoimmunity of organs, degenerative diseases of the CNS and cancer).
Molecular events and interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airway remodelling.
Biomarkers that define the therapeutic response in asthma.
New antiallergenic drugs and new strategies in the treatment of allergic disease.
Clinical and immune-pharmacological activities of modifiers of biological responses such as cytokines, monoclonal antibodies, specific immunotherapy for allergens, etc.
Results of reported patients and assessment of quality of life in patients with respiratory and allergic diseases.
Prof. Canonica coordinated and conducted more than 50 tests (phase II-IV) according to current GCP rules (certification number 2426574, 29/06/2017).
He has also served as an arbitrator for most of the most important international journals - Editor-in-Chief of "Current Opinion in Allergy and Clinical Immunology" – Associated Editor "Annals of Allergy & Clinical Immunology".
Previous experience:
Director of the Degree programme of Lung Diseases at the University of Genoa (1998 - Today) President of the Clinic for Diseases of Allergies and Respiratory - Department of Internal Medicine, University of Genoa - IRCCS AOU San Martino IST
(1997) Director of the Specialized School of Allergy and Clinical Immunology DIMI, University of Genoa
Publications:
https://www.ncbi.nlm.nih.gov/pubmed/?term=giorgio+walter+canonica